• Home
  • >Newsletters & Publications
Publications

Newsletters & Publications

2011
A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel
 
Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies
 
Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles
 
Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials
 
Drug Delivery and Translational Research Special Focus Issue on “Advances in Vaginal Drug Delivery"
 
CONRAD Newsletter - June 15, 2011
 
Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections
 
Advances in vaginal drug delivery
 
Ethylene vinyl acetate intravaginal rings for the simultaneous delivery of the antiretroviral UC781 and contraceptive levonorgestrel
 
Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices
 
CONRAD Newsletter - May 16, 2011
 
Reddy female condom: functional performance of a 90-mm shaft length in two clinical studies
 
Preclinical evaluation of UC781 microbicide vaginal drug delivery
 
Synthesis and biological evaluation of fatty acyl ester derivatives of 2′,3′-didehydro-2′,3′-dideoxythymidine
 
Role of semen in HIV-1 transmission: Inhibitor or facilitator?
 
Synthesis and anti-HIV activities of bis-(cycloSaligenyl) pronucleotides derivatives of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine
 
A Promise for Prevention
 
Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection
2010
Recent Trends in Microbicide Formulations
 
Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets
 
Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
 
Novel approaches to vaginal delivery and safety of microbicides: Biopharmaceuticals, nanoparticles, and vaccines
 
Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers
 
Preventing mucosal HIV transmission with topical microbicides: Challenges and opportunities
 
Pharmaceutical development of microbicide drug products
 
Synthesis, antiviral and contraceptive activities of nucleoside-sodium cellulose sulfate acetate and succinate conjugates
 
Design of a semisolid vaginal microbicide gel by relating composition to properties and performance
 
One year follow-up of women with unfulfilled postpartum sterilization requests
 
Baseline factors associated with incident HIV and STI in four microbicide trials
 
Post-cesarean delivery infectious morbidity: focus on preoperative antibiotics and methicillan-resistant Staphylococcus aureus
 
CONRAD Newsletter - September 12, 2010
 
Development of a microbicide-releasing diaphragm as an HIV prevention strategy
 
Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions
 
Innate immunity and inflammatory response to trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition
 
CONRAD Newsletter - April 1, 2010
 
Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function
 
Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads
 
Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y® Jelly
 
In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide
View Archived Publications

Workshops
December 1, 2010
Proceedings from Trends in Microbicide Formulations Workshop held January 25-26, 2010
View All Workshops